Winton Group LTD Eagle Pharmaceuticals, Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $15,557 - $27,949	877 Added 3.75%	24,234 $471,000
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $89,815 - $122,178	3,584 Added 18.13%	23,357 $662,000
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $281,074 - $447,492	-11,252 Reduced 36.27%	19,773 $577,000
Q3 2022 Nov 10, 2022	BUY	$26.42 - $47.12 $250,223 - $446,273	9,471 Added 43.94%	31,025 $820,000
Q2 2022 Aug 10, 2022	BUY	$41.26 - $51.35 $215,542 - $268,252	5,224 Added 31.99%	21,554 $958,000
Q1 2022 May 11, 2022	BUY	$44.58 - $52.6 $276,306 - $326,014	6,198 Added 61.17%	16,330 $808,000
Q4 2021 Feb 10, 2022	SELL	$45.82 - $56.9 $474,695 - $589,484	-10,360 Reduced 50.56%	10,132 $516,000
Q3 2021 Oct 28, 2021	SELL	$43.79 - $55.78 $173,758 - $221,335	-3,968 Reduced 16.22%	20,492 $1.14 Million
Q2 2021 Aug 10, 2021	SELL	$36.86 - $44.5 $87,616 - $105,776	-2,377 Reduced 8.86%	24,460 $1.05 Million
Q1 2021 Jul 21, 2021	BUY	$40.32 - $50.97 $395,337 - $499,760	9,805 Added 57.57%	26,837 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $517,828 - $637,232	-12,412 Reduced 42.15%	17,032 $793,000
Q3 2020 Oct 30, 2020	SELL	$37.02 - $51.28 $3.27 Million - $4.53 Million	-88,299 Reduced 74.99%	29,444 $1.25 Million
Q2 2020 Aug 05, 2020	SELL	$43.24 - $55.02 $1.02 Million - $1.3 Million	-23,628 Reduced 16.71%	117,743 $5.65 Million
Q1 2020 May 11, 2020	SELL	$34.37 - $60.07 $441,757 - $772,079	-12,853 Reduced 8.33%	141,371 $6.5 Million
Q4 2019 Feb 13, 2020	BUY	$54.32 - $64.31 $8.03 Million - $9.51 Million	147,848 Added 2318.82%	154,224 $9.27 Million
Q3 2019 Nov 08, 2019	BUY	$53.25 - $59.98 $38,872 - $43,785	730 Added 12.93%	6,376 $361,000
Q2 2019 Jul 08, 2019	BUY	$46.61 - $58.45 $263,160 - $330,008	5,646 New	5,646 $314,000
Q1 2019 May 13, 2019	SELL	$38.66 - $51.82 $9.17 Million - $12.3 Million	-237,080 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$36.72 - $67.73 $8.71 Million - $16.1 Million	237,080 New	237,080 $9.55 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account